The inhibitory effect of the 6F6 mAb on tumor growth was confirmed in mice xenografted with DiFi CRC cells (wild type KRAS) that overexpress CLDN1 (p = 0.03) (Fig. 6c). Here, KRAS is linked to neoplasm.